Drugs / Bosinji
Bosinji
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03790033 | Dec 2018 → Aug 2019 | — | Gachon University Gil Oriental Medical Hospital | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT03386149 | Dec 2017 → Dec 2019 | lumbar disk disease | Kyunghee University Medical Center | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bosinji | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03386149 ↗ |
| Known as | UCHA | “Ucha-Shinki-Hwan (UCHA) is widely used in the treatment of various diseases including CHHF by harmonizing Yin and Yang, and improving the vitality of whole body.” PMID 32080084 ↗ Feb 2020 |
| Known as | Ucha-Shinki-Hwan | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03790033 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The effectiveness of Bosinji, one of the herbal medicines used for low back pain and radiating pain in patient with LHIVD” PMID 30558079 ↗ Dec 2018 |
| Route | Oral | “2.5g of Bosinji granule (Tsumura \& Co., Tokyo, Japan) will be orally administered” NCT03386149 ↗ |